Friday, 20 Jul 2018

Bangla Version

Advent Pharma to raise Tk 200m

No icon Pharmaceuticals

Health Desk: 07 January 2018: The securities regulator has approved Advent Pharma's IPO proposal to raise Tk 200 million from public.

The approval came at a meeting held at the office of Bangladesh Securities and Exchange Commission (BSEC) recently.

Using the fixed-price method, Advent Pharma will float 20 million ordinary shares of Tk 10 each to raise the said amount.

The company reported its net asset value (NAV) of Tk 12.45 per share, without revaluation, according to financial statement for the year ended on June 30, 2017.